Crossing the Finish Line in the Race to Cure Cancer

06.05.14 | By

Our members are diligently working to bring new medicines to patients. To date, these treatments have helped make some of the most devastating diseases, including HIV, manageable conditions. To do the same for cancer, collaboration across the health care ecosystem is necessary.

Highlighting Progress in Fight Against Parkinson’s Disease with Conversations’ New Look

03.27.14 | By

This week’s Medicines in Development report for Parkinson’s disease examines the work currently underway to help the 1.5 million Americans who are affected by the progressive neurological condition. While high-profile Parkinson’s patients like Michael J.

Increasing Clinical Trial Participation Among Diverse Patient Populations

03.19.14 | By

The development of new medical breakthroughs depends on the patients who volunteer to participate in clinical trials, but according to the Center for Information and Study on Clinical Research Participation, only 6 percent of clinical trials are completed on time and half of clinical research sites enroll one or no patients in their study.

Conversations

If implemented, what would the recent proposed changes to Medicare Part D’s six protected classes mean for patients?

Contributors Respond

Collaborating for Future Progress

02.26.14 | By

The existing model of bringing new medicines to patients is a costly, exhaustive, and thorough process. In fact, to develop a new medicine under the federal process takes about $1 billion and 10 years — with a failure rate of roughly 99 percent.

Conversations

What are some realistic expectations that can come from the Accelerating Medicines Partnership?

Contributors Respond

Conversations

What are our greatest challenges as we address managing chronic diseases like diabetes?

Contributors Respond

Conversations

Every 34 seconds someone has a heart attack in the United States. How can we work together to improve prevention and treatment of cardiovascular disease to save lives?

Contributors Respond

Conversations

Smartphones, tablets and other mobile devices have become part of our everyday lives. How can we harness these technologies and platforms to manage chronic diseases and improve patient health?

Contributors Respond

Pages

Subscribe to RSS - conversations